Data from multiple sources - Curated by Marshall Pearce - Last updated 06 June 2017
Added 1 month ago Drug news
UK NICE recommends use of Stivarga (regorafenib) in adults with gastrointestinal stromal tumours.- Bayer HealthCare.
The UK National Institute for Health and Care Excellence has backed Stivarga (regorafenib), from Bayer Healthcare, as a cost-effective option...
Added 5 months ago Drug news
Successful Phase I trial of BLU 285 for gastrointestinal stromal tumors is basis for initiating Phase III trial in 2018.- BluePrint Medicines
Blueprint Medicines Corporation announced new Phase 1 clinical data and outlined registration plans for BLU 285, a potent and highly...
Added 1 year ago Drug news
German Institute for Quality and Efficiency in Health Care suggests no additional benefit of Halaven (eribulin) in liposarcomas- Eisai
The German Institute for Quality and Efficiency in Health Care (IQWiG) has published a report which suggests that on formal...
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
Watch video hightlights from the BeCOn OWN 2017 event, including expert opinion, patient experience and panel discussions in the Breakthrough Cancer Pain Learning Zone.
See information on best practice in solid organ transplantation, and expert discussions on related hot topics.
Since its introduction into clinical practice in the UK 26 years ago, positorn emission tomography (PET) followed by positron emission tomography-computed tomography...
Added 11 months ago
Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best...
Added 3 years ago
Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study.
Cancer is the second leading cause of death worldwide. Current estimates on the burden of cancer are needed for cancer control planning.
Added 2 months ago
The main goals were to study the safety and tolerability of the alpha-emitter radium-223 (223Ra) in breast and prostate cancer patients with skeletal metastases. In addition, pain palliation was evaluated.
Added 6 months ago
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial.
Background: A non-randomised, phase 2 study showed activity and tolerability of eribulin in advanced or metastatic soft-tissue sarcoma. In this...
Added 1 year ago
Fiona worked in the fitness and wellness industry in the US for 13 years, supporting behaviour change in a variety of settings. Fiona’s research interests lie broadly within health and wellbeing. She is particularly interested in qualitative methodologies in the areas of body image ... Read more
Ahead of World Cancer Day on Saturday (February 4), Fiona Holland, Psychology Lecturer, discusses what to say and what not to say to someone with cancer.